195 related articles for article (PubMed ID: 29409858)
1. Cost of unintended pregnancy in Sweden - a possibility to lower costs by increasing LARC usage.
Engstrand S; Kopp Kallner H
Contraception; 2018 May; 97(5):445-450. PubMed ID: 29409858
[TBL] [Abstract][Full Text] [Related]
2. The Cost of Unintended Pregnancies in Canada: Estimating Direct Cost, Role of Imperfect Adherence, and the Potential Impact of Increased Use of Long-Acting Reversible Contraceptives.
Black AY; Guilbert E; Hassan F; Chatziheofilou I; Lowin J; Jeddi M; Filonenko A; Trussell J
J Obstet Gynaecol Can; 2015 Dec; 37(12):1086-97. PubMed ID: 26637081
[TBL] [Abstract][Full Text] [Related]
3. Cost-benefit analysis of enhancing the uptake of long-acting reversible contraception in Australia.
Concepcion K; Lacey S; McGeechan K; Estoesta J; Bateson D; Botfield J
Aust Health Rev; 2020 Jun; 44(3):385-391. PubMed ID: 31655632
[TBL] [Abstract][Full Text] [Related]
4. Cost of unintended pregnancy in Norway: a role for long-acting reversible contraception.
Henry N; Schlueter M; Lowin J; Lekander I; Filonenko A; Trussell J; Skjeldestad FE
J Fam Plann Reprod Health Care; 2015 Apr; 41(2):109-15. PubMed ID: 25537792
[TBL] [Abstract][Full Text] [Related]
5. Achieving cost-neutrality with long-acting reversible contraceptive methods.
Trussell J; Hassan F; Lowin J; Law A; Filonenko A
Contraception; 2015 Jan; 91(1):49-56. PubMed ID: 25282161
[TBL] [Abstract][Full Text] [Related]
6. Retrospective analysis of the impact of increasing access to long acting reversible contraceptives in a commercially insured population.
Law A; Pilon D; Lynen R; Laliberté F; Gozalo L; Lefebvre P; Duh MS
Reprod Health; 2016 Aug; 13(1):96. PubMed ID: 27549429
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness analysis of a low-dose contraceptive levonorgestrel intrauterine system in Sweden.
Henry N; Hawes C; Lowin J; Lekander I; Filonenko A; Kallner HK
Acta Obstet Gynecol Scand; 2015 Aug; 94(8):884-90. PubMed ID: 26015090
[TBL] [Abstract][Full Text] [Related]
8. Not seeking yet trying long-acting reversible contraception: a 24-month randomized trial on continuation, unintended pregnancy and satisfaction.
Hubacher D; Spector H; Monteith C; Chen PL
Contraception; 2018 Jun; 97(6):524-532. PubMed ID: 29470950
[TBL] [Abstract][Full Text] [Related]
9. Cost Minimization Analysis of Same-Day Long-Acting Reversible Contraception for Adolescents.
Wilkinson TA; Downs SM; Tucker Edmonds B
JAMA Netw Open; 2019 Sep; 2(9):e1911063. PubMed ID: 31509208
[TBL] [Abstract][Full Text] [Related]
10. Burden of unintended pregnancy in the United States: potential savings with increased use of long-acting reversible contraception.
Trussell J; Henry N; Hassan F; Prezioso A; Law A; Filonenko A
Contraception; 2013 Feb; 87(2):154-61. PubMed ID: 22959904
[TBL] [Abstract][Full Text] [Related]
11. Increasing uptake of long-acting reversible contraception with structured contraceptive counselling: cluster randomised controlled trial (the LOWE trial).
Emtell Iwarsson K; Envall N; Bizjak I; Bring J; Kopp Kallner H; Gemzell-Danielsson K
BJOG; 2021 Aug; 128(9):1546-1554. PubMed ID: 33988917
[TBL] [Abstract][Full Text] [Related]
12. Comparison of unintended pregnancy at 12 months between two contraceptive care programs; a controlled time-trend design.
Madden T; Paul R; Maddipati R; Buckel C; Goodman M; Peipert JF
Contraception; 2019 Sep; 100(3):196-201. PubMed ID: 31132346
[TBL] [Abstract][Full Text] [Related]
13. Factors Associated with New Uptake of Long-Acting Reversible Contraceptives Since the Affordable Care Act Among Privately Insured Women in Pennsylvania.
Nelson HN; Thayer E; Bailey C; Leuenberger L; Lehman E; Chuang CH
Womens Health Issues; 2019; 29(5):370-375. PubMed ID: 31337530
[TBL] [Abstract][Full Text] [Related]
14. Unintended pregnancy and subsequent postpartum long-acting reversible contraceptive use in Zimbabwe.
Nance N; Ralph L; Padian N; Cowan F; Buzdugan R; Mushavi A; Mahomva A; McCoy SI
BMC Womens Health; 2018 Nov; 18(1):193. PubMed ID: 30477497
[TBL] [Abstract][Full Text] [Related]
15. Predictors of choosing long-acting reversible contraceptive methods when provided free-of-charge - A prospective cohort study in Finland.
Gyllenberg F; Saloranta T; But A; Gissler M; Heikinheimo O
Contraception; 2020 Jun; 101(6):370-375. PubMed ID: 32061566
[TBL] [Abstract][Full Text] [Related]
16. Long-acting reversible contraceptive use in the post-abortion period among women seeking abortion in mainland China: intentions and barriers.
Luo Z; Gao L; Anguzu R; Zhao J
Reprod Health; 2018 May; 15(1):85. PubMed ID: 29793501
[TBL] [Abstract][Full Text] [Related]
17. Cost sharing, postpartum contraceptive use, and short interpregnancy interval rates among commercially insured women.
Moniz MH; Peahl AF; Fendrick AM; Kolenic GE; Tilea A; Wetmore M; Dalton VK
Am J Obstet Gynecol; 2021 Mar; 224(3):282.e1-282.e17. PubMed ID: 32898503
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness and cost of contraception in France (FACET study): a cohort study from the French National Healthcare Insurance Database.
Agostini A; Godard C; Laurendeau C; Benmahmoud A; Lafuma A; Doz M; Lévy-Bachelot L; Gourmelen J; Linet T
Eur J Obstet Gynecol Reprod Biol; 2018 Oct; 229():137-143. PubMed ID: 30176517
[TBL] [Abstract][Full Text] [Related]
19. Contraception after Abortion and Risk of Repeated Unintended Pregnancy among Health Plan Members.
Postlethwaite D; Lee J; Merchant M; Alabaster A; Raine-Bennett T
Perm J; 2018; 22():18-058. PubMed ID: 30227910
[TBL] [Abstract][Full Text] [Related]
20. Direct costs of unintended pregnancy in Spain.
Lete I; Hassan F; Chatzitheofilou I; Wood E; Mendivil J; Lambrelli D; Filonenko A
Eur J Contracept Reprod Health Care; 2015; 20(4):308-18. PubMed ID: 25843298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
